Global Pharmacovigilance: TFS Orchestrates a Post-Marketing PV System

Download our case study to:

Discover how an oncology sponsor preparing for their first product approval successfully transitioned from the clinical to the post-approval phase and how TFS navigated through the complex task of consolidating safety data scattered across multiple CRO databases, implementing a new safety database, and setting up a post-marketing Pharmacovigilance (PV) system.

Learn about the effective strategies employed to ensure streamlined reporting, rapid decision-making, and efficient project tracking. TFS’ innovative approach of establishing a partnership framework, integrating the quality management systems of both parties, will be particularly interesting for those grappling with similar challenges. Download this case study to observe a compelling example of TFS’s expertise and commitment in the face of complex transitional challenges.

Learn more about our related services and resources:

TFS Oncology & Hematology | TFS Strategic Resourcing Solutions

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology Expertise

Sarcoma
Up to 1 in 3 sarcoma diagnoses change on second reviewArticle

Up to 1 in 3 sarcoma diagnoses change on second review

TFS HealthScience on what sponsors should ask before a sarcoma programme begins and how we build protocols around real clinical practice.
The new endpoints reshaping oncology trial designWebinars

The new endpoints reshaping oncology trial design

The endpoint and eligibility shifts reshaping oncology trial design in 2026. Watch the full replay or download the slides.
RWD
Getting real-world evidence to the sponsor before the deadline, not afterCase Study

Getting real-world evidence to the sponsor before the deadline, not after

When a tight oncology RWE deadline moved forward by 10 days, TFS HealthScience restructured the team and delivered. Download the case study to find out how.